---
title: Blood biomarker fingerprints in a cohort of patients with CHRNE-related congenital
  myasthenic syndrome
date: '2025-02-13'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39948634/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250214170344&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Mutations in CHRNE encoding the epsilon subunit of acetylcholine receptor
  result in impaired neuromuscular transmission and congenital myasthenic syndrome
  (CMS) with variying severity of symptoms. Although the pathophysiology is well-known,
  blood biomarker signatures enabling a patient-stratification are lacking. This retrospective
  two-center-study includes 19 recessive CHRNE-patients (AChR deficiency; mean age
  14.8 years) from 13 families which were clinically characterized according to ...
disable_comments: true
---
Mutations in CHRNE encoding the epsilon subunit of acetylcholine receptor result in impaired neuromuscular transmission and congenital myasthenic syndrome (CMS) with variying severity of symptoms. Although the pathophysiology is well-known, blood biomarker signatures enabling a patient-stratification are lacking. This retrospective two-center-study includes 19 recessive CHRNE-patients (AChR deficiency; mean age 14.8 years) from 13 families which were clinically characterized according to ...